Discontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients.

Bally, Klaus

Discontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients. [electronic resource] - Swiss medical weekly 2013 - w13896 p. digital

Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

1424-3997

10.4414/smw.2013.13896 doi


Adrenergic beta-Antagonists--therapeutic use
Adult
Aged
Aged, 80 and over
Angiotensin Receptor Antagonists--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Aspirin--therapeutic use
Clopidogrel
Female
General Practice--methods
Guideline Adherence--statistics & numerical data
Humans
Male
Middle Aged
Myocardial Infarction--drug therapy
Platelet Aggregation Inhibitors--therapeutic use
Practice Guidelines as Topic
Secondary Prevention--methods
Surveys and Questionnaires
Ticlopidine--analogs & derivatives
Assessment of Medication Adherence